Austin, TX 10/19/2007 9:31:49 PM
News / Finance

Speak with other shareholders about: (NASDAQ: DELL), (OTCBB: THPW), (NASDAQ: SNDK), (OTCBB: GLIF), (Nasdaq: NKTR).

AUSTIN, TX: October 19, 2007 – Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the “Chat Live” button at the top.

                                                             

Chat real-time with other investors about this DELL news release, by
clicking this link: http://www.stockwire.com/DELL

 

To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=DELL

 

Dell (NASDAQ: DELL), up 1% on 23 million shares, yesterday issued a global challenge to members of the "ReGeneration" - people of all ages who share a goal of protecting the Earth - to help its engineers design the world's most environmentally responsible computing technology.

----------------------------------------------------------

                                                                            

Chat real-time with other investors about this THPW news release, by
clicking this link: http://www.stockwire.com/THPW

 

To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=THPW


Thorium Power, Ltd. (OTCBB: THPW), down 7% on 8 million shares, the leading developer of low-waste, non-proliferative nuclear fuel technology for existing and future reactors, announced Thursday the participation of CEO Seth Grae in the upcoming International Atomic Energy Agency (IAEA) conference on: Thorium-Based Fuels and Fuel Cycle Options for Existing Reactors. This IAEA conference will be held from October 22-25, 2007 in Istanbul, Turkey, and is being hosted by the Turkish Atomic Energy Authority.

----------------------------------------------------------

                                                                            

Chat real-time with other investors about this SNDK news release, by
clicking this link: http://www.stockwire.com/SNDK

 

To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=SNDK


SanDisk(R) Corporation (NASDAQ: SNDK), up 2% on 19 million shares, the world's largest supplier of flash storage card products, yesterday announced results for the third quarter ended September 30, 2007. Third quarter revenue increased 38% on a year-over-year basis to $1.037 billion and net income in accordance with U.S. Generally Accepted Accounting Principles (GAAP) increased to $85 million, or $0.36 per diluted share, compared to GAAP net income of $28 million, or $0.12 per diluted share, in the second quarter of 2007. GAAP net income was $103 million, or $0.51 per diluted share, in the third quarter of 2006.

----------------------------------------------------------

                                                                            

Chat real-time with other investors about this GLIF news release, by
clicking this link: http://www.stockwire.com/GLIF

 

To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=GLIF


Grant Life Sciences Inc. (OTCBB: GLIF), down 12% on 6 million shares, announced Wednesday the signing of a final agreement with Dr. Peter Sveshnikov and Dr. Vsevolod Kiselev of the Russian Federation, for the in-licensing of certain of their technologies that are highly complementary to Grants' antibody-based test for detecting cervical cancer.

----------------------------------------------------------

                                                                            

Chat real-time with other investors about this NKTR news release, by
clicking this link: http://www.stockwire.com/NKTR

 

To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=NKTR


Nektar Therapeutics (Nasdaq: NKTR), down 17% on 17 million shares, issued a statement yesterday in response to Pfizer's announcement this morning to exit Exubera, the inhaled insulin product to treat diabetes. "We first learned this morning of Pfizer's decision to walk away from Exubera from their press release," said Howard W. Robin, President and Chief Executive Officer of Nektar Therapeutics. "Nektar has been very disappointed in Pfizer's performance in marketing Exubera. Pfizer has publicly acknowledged its organizational difficulties and resulting poor performance in launching Exubera. This has culminated in their announcement today. We are evaluating all of our options with respect to Pfizer's Exubera announcement to protect the interests of Nektar.

----------------------------------------------------------

 

As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.

 

As the saying goes...follow the money!

 

To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .

 

About Stockwire:

Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.

 

The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.

 

Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.

 

As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.

 

While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

 

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE RESEARCH GROUP INC..

 

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.

 

Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml

 

Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.

 

From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

 

Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com, which is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.

 

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

 

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.

 

We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares at any given time.

 

While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .

 

The Stockwire Group .

512.358.8440 .

info@stockwire.com .